Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04406272
Title VB-111 in Surgically Accessible Recurrent/Progressive GBM
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California, Los Angeles (UCLA) Los Angeles California 90095 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02115 United States Details
UT Health San Antonio MD Anderson Cancer Center (Mays Cancer Center) San Antonio Texas 78229 United States Details
Huntsman Cancer Institute (HCI), University of Utah Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field